Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,923 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,923 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,923 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,923 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,923 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,923 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,923 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
21 Jan 2026
Nottebohm Olivia Chief Operating Officer
Sold on a plan
$120.10K 4,612 at 26.04
1.0%
Planned (10b5-1)
21 Jan 2026
Costanza Kelly Chief People Officer
Sold at will
$114.73K 1,702 at 67.41
1.4%
Not planned
21 Jan 2026
Rosenberg Nick Executive Vice President
Sold on a plan
$112.77K 1,250 at 90.21
4.6%
Planned (10b5-1)
21 Jan 2026
Cislini Jeff General Counsel
Sold on a plan
$104.96K 908 at 115.60
1.9%
Planned (10b5-1)
21 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$102.93K 438 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Tregillis Cynthia L Chief Legal Officer & Corp Sec
Sold on a plan
$102.36K 447 at 229.00
0.3%
Planned (10b5-1)
21 Jan 2026
Domino Michael Wayne Jr. President, DTR Division
Sold on a plan
$99.98K 24,996 at 4.00
1.7%
Planned (10b5-1)
21 Jan 2026
Yi Steven See Remarks
Sold on a plan
$88.18K 8,000 at 11.02
0.3%
Planned (10b5-1)
21 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$79.67K 339 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
O'Connor Casey Chief Legal Officer
Sold on a plan
$73.97K 13,852 at 5.34
2.5%
Planned (10b5-1)
21 Jan 2026
Bertram Kenneth Robert CLO & Secretary
Sold at will
$72.40K 1,074 at 67.41
2.1%
Not planned
21 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$68.86K 293 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Xenohristos Theodoros Chief Concept Officer
Sold at will
$65.05K 965 at 67.41
0.3%
Not planned
21 Jan 2026
Vanderhook Christopher Chief Operating Officer · indirect
Sold on a plan
$60.30K 4,926 at 12.24
65.7%
Sold half or more
21 Jan 2026
Stout Jay S Chief Technology Officer
Sold at will
$51.46K 1,977 at 26.03
1.0%
Not planned
21 Jan 2026
Gavel Steve Chief Commercial Officer
Bought
$50.22K 22,170 at 2.27
opened
First buy on file
21 Jan 2026
SMITH J. JEFFERSON Chief Research Officer
Sold on a plan
$41.11K 10,200 at 4.03
8.5%
Planned (10b5-1)
21 Jan 2026
Roberts Zachary EVP of R&D
Sold at will
$40.98K 26,269 at 1.56
4.1%
Not planned
21 Jan 2026
Scimeca Dario General Counsel and Secretary
Sold on a plan
$35.68K 8,854 at 4.03
16.5%
Planned (10b5-1)
21 Jan 2026
Gleason Shane Thomas Chief Commercial Officer
Sold at will
$28.55K 17,593 at 1.62
1.5%
Not planned
21 Jan 2026
Cree Brian President
Sold on a plan
$28.36K 1,440 at 19.69
0.3%
Planned (10b5-1)
21 Jan 2026
Binder Gwendolyn President, Science & Tech.
Bought
$24.76K 11,312 at 2.19
56.6%
First buy in 3+ yrs
21 Jan 2026
Platzer Peter Executive Chairman
Sold on a plan
$21.79K 1,801 at 12.10
0.1%
Planned (10b5-1)
21 Jan 2026
Kirol Charles Peter Chief Operating Officer
Sold on a plan
$19.90K 3,399 at 5.85
4.2%
Planned (10b5-1)
21 Jan 2026
Chang David J. Chief Medical Officer
Bought
$19.89K 8,800 at 2.26
opened
First buy on file
21 Jan 2026
Gerard Michael General Counsel
Bought
$14.98K 6,600 at 2.27
opened
First buy on file
21 Jan 2026
Agah Ramtin Chief Medical Officer
Bought
$9.98K 10,000 at 1.00
1.3%
21 Jan 2026
Moreadith Randall Chief Scientific Officer
Sold on a plan
$6.00K 2,000 at 3.00
100%
Sold half or more
21 Jan 2026
Brottem John L. General Counsel
Sold at will
$5.91K 1,180 at 5.01
3.2%
Not planned
21 Jan 2026
Nash Marc EVP Operations R&D & Service
Sold at will
$4.88K 980 at 4.98
2.3%
Not planned
21 Jan 2026
Siemers Eric Chief Medical Officer
Sold at will
$4.20K 2,331 at 1.80
0.9%
Not planned
21 Jan 2026
Barton Russell Chief Operating Officer
Sold at will
$4.18K 2,315 at 1.81
1.1%
Not planned
21 Jan 2026
Meisner Derek M Chief Legal Officer & Corp Sec
Sold at will
$4.06K 2,247 at 1.81
1.2%
Not planned
21 Jan 2026
STAHL MURRAY President/Co-Portfolio Manager · indirect
Bought 6×
$2.09K 774 at 2.70
0.2%
21 Jan 2026
Abate Kristin Chief Accounting Officer
Sold at will
$1.58K 265 at 5.96
1.2%
Not planned
21 Jan 2026
STAHL MURRAY President/Co-Portfolio Manager
Bought
$972.00 360 at 2.70
0.3%
20 Jan 2026
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 28×
$10.45M 22,500 at 464.66
100%
Sold half or more
20 Jan 2026
McBee Brannin Chief Development Officer
Sold on a plan 5×
$9.80M 102,835 at 95.29
29.3%
Planned (10b5-1)
20 Jan 2026
Biswas Sanjit CHIEF EXECUTVE OFFICER · indirect
Sold on a plan 6×
$8.56M 263,900 at 32.43
77.0%
Sold half or more
20 Jan 2026
Bicket John SEE REMARKS · indirect
Sold on a plan 6×
$8.56M 263,900 at 32.43
77.0%
Sold half or more
20 Jan 2026
Wong Jennifer L. Chief Operating Officer
Sold on a plan 9×
$6.13M 27,159 at 225.73
2.3%
Planned (10b5-1)
20 Jan 2026
McBee Brannin Chief Development Officer · indirect
Sold on a plan 35×
$6.08M 63,835 at 95.29
100%
Sold half or more
20 Jan 2026
SAPERSTEIN ANDREW M Co-President
Sold at will 6×
$5.57M 30,330 at 183.62
9.8%
Not planned
20 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$5.45M 23,205 at 234.74
13.8%
Planned (10b5-1)
20 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$4.51M 19,234 at 234.74
7.8%
Planned (10b5-1)
20 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$4.18M 17,806 at 234.74
9.1%
Planned (10b5-1)
20 Jan 2026
GROSSMAN ERIC F Chief Legal/Admin Officer
Sold at will
$3.97M 21,555 at 184.00
11.2%
Not planned
20 Jan 2026
Duda Kenneth President and CTO
Sold on a plan 4×
$3.85M 30,000 at 128.43
69.8%
Sold half or more
20 Jan 2026
Pizzi Michael A. Head Technology & Operations
Sold at will
$3.69M 20,000 at 184.55
13.5%
Not planned
20 Jan 2026
Duda Kenneth President and CTO · indirect
Sold on a plan 8×
$3.34M 26,000 at 128.43
4.7%
Planned (10b5-1)
Showing 18,101–18,150 of 22,923. ← Newer Page 363 of 459 Older →